LOC102724946: A Potential Drug Target or Biomarker (G102724946)

Target Name: Uncharacterized LOC102724946, transcript variant X3

NCBI ID: G102724946

Uncharacterized LOC102724946, transcript variant X3

Other Name(s): LOC102724946 variant X3

LOC102724946: A Potential Drug Target or Biomarker

Abstract:

LOC102724946 is a gene that encodes a protein known as located within intron 2 of the gene HBA_12.1. This gene has not been characterized previously, but its function and potential drug targets or biomarkers are under investigation. The LOC102724946 protein is a cytoplasmic protein that is involved in various cellular processes, including cell adhesion, migration, and invasion. It is also known to be involved in the development and progression of various diseases, including cancer. This protein is a potential drug target or biomarker, and its research could lead to new treatments and therapies for various diseases.

Introduction:

LOC102724946 is a gene that encodes a cytoplasmic protein located within intron 2 of the gene HBA_12.1. This gene has not been previously characterized, and its function and potential drug targets or biomarkers are under investigation. The LOC102724946 protein is involved in various cellular processes, including cell adhesion, migration, and invasion, and is also known to be involved in the development and progression of various diseases, including cancer. This protein is a potential drug target or biomarker, and its research could lead to new treatments and therapies for various diseases.

Location of the LOC102724946 gene:

The LOC102724946 gene is located within the chromosome 12.1. Chromosomes are the genetic units that contain the instructions for building proteins. Each chromosome has a unique sequence of DNA, known as an gene. The LOC102724946 gene is a member of the HBA gene family, which is located on chromosome 12.1.

Function of the LOC102724946 protein:

The LOC102724946 protein is a cytoplasmic protein that is involved in various cellular processes, including cell adhesion, migration, and invasion. It is also involved in the development and progression of various diseases, including cancer. The LOC102724946 protein is thought to play a role in cell-cell adhesion by interacting with the protein E-cadherin. This interaction may help to regulate the movement of cells along the body's surface and also may be involved in the development of cancer.

Potential Drug Targets or Biomarkers:

The LOC102724946 protein is a potential drug target or biomarker, and its research could lead to new treatments and therapies for various diseases. Its role in cell-cell adhesion and its involvement in the development and progression of cancer make it a promising target for drug development. Additionally, the LOC102724946 protein may also be used as a biomarker for monitoring the effectiveness of various treatments.

Conclusion:

LOC102724946 is a gene that encodes a cytoplasmic protein located within intron 2 of the gene HBA_12.1. This protein is involved in various cellular processes, including cell adhesion, migration, and invasion, and is also known to be involved in the development and progression of various diseases, including cancer. As a potential drug target or biomarker, the LOC102724946 protein is under investigation for its role in the development and progression of various diseases. Further research is needed to fully understand the function of this protein and its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC102724946, Transcript Variant X3

The "Uncharacterized LOC102724946, transcript variant X3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Uncharacterized LOC102724946, transcript variant X3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets